Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Dr. Wolff Finland Oy
OY
Active
Y-tunnus 3231578-7
Erottajankatu 2, 00120
Helsinki
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 2021
5 employees
Watchlist
Share
Finland
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Dr. Wolff Finland Oy
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
0M
148M
297M
445M
593M
4M
2022
516M
2023
5M
2024
EBITDA
EUR millions
0M
6M
12M
17M
23M
0M
2022
20M
2023
0M
2024
Income statement
EUR thousands
Item
2022
2023
2024
Revenue
4 202
515 644
5 478
Staff expenses
−508
−64 789
−591
EBITDA
192
19 713
287
Depreciation & amort.
−2
−137
−1
EBIT
190
19 576
286
Net financials
−15
−23
−16
Profit before tax
175
17 317
269
Tax
4
39
57
Net profit
171
13 374
212
Balance sheet
EUR thousands
Item
2022
2023
2024
Total assets
2 101
2 604
2 159
Equity
13
147
359
Long-term debt
830
1 000
500
Short-term debt
1 259
1 458
1 300
Total debt
2 088
2 458
1 800
Financial ratios
5-year trend
EBITDA margin
5.2%
This company
15.8%
Market median
-67% vs market
2022
2024
Equity ratio
16.6%
This company
38.2%
Market median
-57% vs market
2022
2024
Return on equity
59.2%
This company
18.4%
Market median
+222% vs market
2022
2024
Net profit margin
3.9%
This company
8.1%
Market median
-52% vs market
2022
2024
Asset turnover
2.54×
This company
1.12×
Market median
+127% vs market
2022
2024
Debt / equity
5.02×
This company
0.62×
Market median
-710% vs market
2022
2024
Annual reports & filings
Annual report 2024
Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
View
PDF
More on Dr. Wolff Finland Oy
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
